ARTICLE | Company News
Biofield, ValiRx deal
January 5, 2009 8:00 AM UTC
Biofield received an exclusive, worldwide license to distribute a human papillomavirus (HPV) diagnostic test for cervical cancer from ValiRx's ValBio S.A. subsidiary. Biofield purchased a 10% equity s...